Cyd dengue virus serotype 4 live (attenuated) antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Dengvaxia
Generic Name
Cyd dengue virus serotype 4 live (attenuated) antigen
DrugBank Accession Number
DB15524
Background

Not Available

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Attenuated
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
DengvaxiaCyd dengue virus serotype 4 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 1 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 2 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 3 live (attenuated) antigen (0.7156818821 CCID50)Injection, powder, for suspensionSubcutaneousSanofi Pasteur2022-06-08Not applicableEU flag
DENGVAXIACyd dengue virus serotype 4 live (attenuated) antigen (100000 CCID50) + Cyd dengue virus serotype 1 live (attenuated) antigen (100000 CCID50) + Cyd dengue virus serotype 2 live (attenuated) antigen (100000 CCID50) + Cyd dengue virus serotype 3 live (attenuated) antigen (100000 CCID50)Injection, powder, for suspensionSubcutaneousSanofi Pasteur2019-10-01Not applicableItaly flag
DENGVAXIACyd dengue virus serotype 4 live (attenuated) antigen (100000 CCID50) + Cyd dengue virus serotype 1 live (attenuated) antigen (100000 CCID50) + Cyd dengue virus serotype 2 live (attenuated) antigen (100000 CCID50) + Cyd dengue virus serotype 3 live (attenuated) antigen (100000 CCID50)Injection, powder, for suspensionSubcutaneousSanofi Pasteur2019-10-01Not applicableItaly flag
DengvaxiaCyd dengue virus serotype 4 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 1 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 2 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 3 live (attenuated) antigen (0.7156818821 CCID50)Injection, powder, for suspensionSubcutaneousSanofi Pasteur2022-06-08Not applicableEU flag
DengvaxiaCyd dengue virus serotype 4 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 1 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 2 live (attenuated) antigen (0.7156818821 CCID50) + Cyd dengue virus serotype 3 live (attenuated) antigen (0.7156818821 CCID50)Injection, powder, for suspensionSubcutaneousSanofi Pasteur2022-06-08Not applicableEU flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
RS26HP5ND2
CAS number
Not Available

References

General References
Not Available
RxNav
2197293

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedPreventionDengue Fever / Dengue Hemorrhagic Fever / Human Papillomavirus Disease2
3TerminatedPreventionDengue Fever / Dengue Hemorrhagic Fever1
2CompletedPreventionDengue Diseases / Dengue Fever / Dengue Hemorrhagic Fever / Dengue Virus1
2CompletedPreventionDengue Fever / Dengue Hemorrhagic Fever / Dengue Virus1
Not AvailableCompletedNot AvailableDengue Fever1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, powder, lyophilized, for suspension; kitSubcutaneous
Injection, powder, for suspensionSubcutaneous5.25 log10 CCID50/dose
Injection, powder, for suspensionSubcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at October 09, 2019 19:54 / Updated at June 12, 2020 16:53